BALAMTRIS Trademark
Trademark Overview
On Friday, February 17, 2023, a trademark application was filed for BALAMTRIS with the United States Patent and Trademark Office. The USPTO has given the BALAMTRIS trademark a serial number of 97799350. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, December 17, 2024. This trademark is owned by Eli Lilly and Company. The BALAMTRIS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
General Information
| Serial Number | 97799350 |
| Word Mark | BALAMTRIS |
| Filing Date | Friday, February 17, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, December 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 28, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 23, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
Trademark Events
| Event Date | Event Description |
| Tuesday, February 21, 2023 | NEW APPLICATION ENTERED |
| Thursday, February 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 25, 2023 | ASSIGNED TO EXAMINER |
| Thursday, October 26, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, June 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 19, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, June 19, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 17, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 17, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, December 17, 2024 | SOU EXTENSION 2 GRANTED |
